FLCN and familial spontaneous pneumothorax: In addition, FLCN mutation analysis should be considered for patients who have familial cystic lung disease, familial pneumothorax, familial renal cancer, or any combination of spontaneous pneumothorax and kidney cancer (Menko et al, 2009).